Markus Gabriel Manz (M Manz, Markus G Manz, Markus Manz)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 66

Top Topics

Hematopoietic Stem Cell

Acute Myeloid Leukemia

Top Venues

EMBO molecular medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jurjen Versluis, Marlen Metzner, Ariel Wang, Patrycja Gradowska, Abin Thomas, Niels Asger Jakobsen, Alison Kennedy, Rachel Moore, Emma Boertjes, Christian M Vonk, Francois G Kavelaars, Melissa Rijken, Amanda Gilkes, Claire Schwab, H Berna Beverloo, Markus Gabriel Manz, Otto Visser, Catharina H M J Van Elssen, Okke de Weerdt, Lidwine W Tick, Bart J Biemond, Marie-Christiane Vekemans, Sylvie D Freeman, Christine J Harrison, Jonathan Alistair Cook, Mike Dennis, Stephen Knapper, Ian Thomas, Charles F Craddock, Gert J Ossenkoppele, Bob Löwenberg, Nigel H Russell, Peter J M Valk, Paresh Vyas
Risk Stratification in Older Intensively Treated Patients With AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine (2024)
Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, Joost van Rosmalen, Thomas Pabst, Johan A Maertens, Dimitri Breems, Markus Gabriel Manz, Jacqueline Cloos, Gert J Ossenkoppele, Yngvar Floisand, Patrycja Gradowska, Bob Löwenberg, Gerwin Huls, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial. Blood cancer journal 14 (1) (2024)
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Sébastien Zangger, Frederik Peissert, Stefanie K Pfister, Christian Pellegrino, Sheila Dakhel, Roberto De Luca, Markus Gabriel Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri
Optimizing the Design and Geometry of T Cell-Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer. Molecular cancer therapeutics 23 (7) (2024)
Francisco Caiado, Markus Gabriel Manz
IL-1 in aging and pathologies of hematopoietic stem cells. Blood 144 (4) (2024)
Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, Joost van Rosmalen, Thomas Pabst, Johan A Maertens, Dimitri Breems, Markus Gabriel Manz, Jacqueline Cloos, Gert J Ossenkoppele, Yngvar Floisand, Patrycja Gradowska, Bob Löwenberg, Gerwin Huls, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial. Blood cancer journal 14 (1) (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine 16 (3) (2024)
Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, Joost van Rosmalen, Thomas Pabst, Johan A Maertens, Dimitri Breems, Markus Gabriel Manz, Jacqueline Cloos, Gert J Ossenkoppele, Yngvar Floisand, Patrycja Gradowska, Bob Löwenberg, Gerwin Huls, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial. Blood cancer journal 14 (1) (2024)
Markus Gabriel Manz, Francisco Caiado
IL-1 in Aging and Pathologies of Hematopoietic Stem Cells. Blood (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine 16 (3) (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine (2024)
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Sébastien Zangger, Frederik Peissert, Stefanie K Pfister, Christian Pellegrino, Sheila Dakhel, Roberto De Luca, Markus Gabriel Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri
Optimizing the design and geometry of T cell engaging bispecific antibodies targeting CEA in colorectal cancer. Molecular cancer therapeutics (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine 16 (4) (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine 16 (3) (2024)
Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, Joost van Rosmalen, Thomas Pabst, Johan A Maertens, Dimitri Breems, Markus Gabriel Manz, Jacqueline Cloos, Gert J Ossenkoppele, Yngvar Floisand, Patrycja Gradowska, Bob Löwenberg, Gerwin Huls, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial. Blood cancer journal 14 (1) (2024)
Francisco Caiado, Markus Gabriel Manz
IL-1 in Aging and Pathologies of Hematopoietic Stem Cells. Blood (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine 16 (4) (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine 16 (3) (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine 16 (4) (2024)
Laura Volta, Renier Myburgh, Christian Pellegrino, Christian Koch, Monique Maurer, Francesco Manfredi, Mara Hofstetter, Anne Kaiser, Florin Schneiter, Jan Müller, Marco Matteo Bühler, Roberto De Luca, Nicholas Favalli, Chiara F Magnani, Timm Schroeder, Dario Neri, Markus Gabriel Manz
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells. Leukemia (2024)
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, Jacqueline Mock, Frauke Seehusen, Abdullah Elsayed, Emanuele Puca, Roberto De Luca, Christian Pellegrino, Thomas Look, Tobias Weiss, Markus Gabriel Manz, Cornelia Halin, Dario Neri, Sheila Dakhel
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO molecular medicine 16 (4) (2024)
Francisco Caiado, Markus Gabriel Manz
IL-1 in aging and pathologies of hematopoietic stem cells. Blood 144 (4) (2024)
Lok Lam Ngai, Diana Hanekamp, Fleur Janssen, Jannemieke Carbaat-Ham, Maaike A M Hofland, Mona M H E Fayed, Angèle Kelder, Laura Oudshoorn-van Marsbergen, Willemijn J Scholten, Alexander N Snel, Costa Bachas, Jesse Marc Tettero, Dimitri A Breems, Thomas Fischer, Bjorn Tore Gjertsen, Laimonas Griskevicius, Gunnar Juliusson, Arjan A van de Loosdrecht, Johan A Maertens, Markus Gabriel Manz, Thomas Pabst, Jakob R Passweg, Kimmo Porkka, Peter J M Valk, Patrycja L Gradowska, Bob Löwenberg, David C de Leeuw, Jeroen J W M Janssen, Gert J Ossenkoppele, Jacqueline Cloos
Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial. Blood (2023)
Alexander Ring, Wolfgang Alexander Sieber, Jan-Dirk Studt, Reto A Schuepbach, Christoph Camille Ganter, Markus Gabriel Manz, Antonia Maria Susanne Müller, Sascha David
Indications and Outcomes of Patients Receiving Therapeutic Plasma Exchange under Critical Care Conditions: A Retrospective Eleven-Year Single-Center Study at a Tertiary Care Center. Journal of clinical medicine 12 (8) (2023)
Klara Kropivsek, Paul Kachel, Sandra Goetze, Rebekka Wegmann, Yasmin Festl, Yannik Severin, Benjamin D Hale, Julien Mena, Audrey van Drogen, Nadja Dietliker, Joëlle Tchinda, Bernd Wollscheid, Markus Gabriel Manz, Berend Snijder
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nature cancer (2023)
Klara Kropivsek, Paul Kachel, Sandra Goetze, Rebekka Wegmann, Yasmin Festl, Yannik Severin, Benjamin D Hale, Julien Mena, Audrey van Drogen, Nadja Dietliker, Joëlle Tchinda, Bernd Wollscheid, Markus Gabriel Manz, Berend Snijder
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nature cancer (2023)
Laura Volta, Markus Gabriel Manz
Twisted: Escape of epitope-edited healthy cells from immune attack. The Journal of experimental medicine 220 (12) (2023)
Alexander Ring, Wolfgang Alexander Sieber, Jan-Dirk Studt, Reto A Schuepbach, Christoph Camille Ganter, Markus Gabriel Manz, Antonia Maria Susanne Müller, Sascha David
Indications and Outcomes of Patients Receiving Therapeutic Plasma Exchange under Critical Care Conditions: A Retrospective Eleven-Year Single-Center Study at a Tertiary Care Center. Journal of clinical medicine 12 (8) (2023)
C Matthias Wilk, Flurin Cathomas, Orsolya Török, Jessica Le Berichel, Matthew D Park, George R Heaton, Pauline Hamon, Leanna Troncoso, Brooks P Scull, Diana Dangoor, Aymeric Silvin, Ryan Fleischmann, Meriem Belabed, Howard Lin, Elias Merad Taouli, Steffen Boettcher, Markus Gabriel Manz, Julia K Kofler, Zhenyu Yue, Sergio A Lira, Florent Ginhoux, John F Crary, Kenneth L McClain, Jennifer L Picarsic, Scott J Russo, Carl E Allen, Miriam Merad
Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration. bioRxiv : the preprint server for biology (2023)
Max J Rieger, Sebastian M Stolz, Antonia M Müller, Rahel Schwotzer, Gayathri Nair, Dominik Schneidawind, Markus Gabriel Manz, Urs Schanz
Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm. Bone marrow transplantation (2023)
Klara Kropivsek, Paul Kachel, Sandra Goetze, Rebekka Wegmann, Yasmin Festl, Yannik Severin, Benjamin D Hale, Julien Mena, Audrey van Drogen, Nadja Dietliker, Joëlle Tchinda, Bernd Wollscheid, Markus Gabriel Manz, Berend Snijder
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nature cancer (2023)
Alexander Ring, Wolfgang Alexander Sieber, Jan-Dirk Studt, Reto A Schuepbach, Christoph Camille Ganter, Markus Gabriel Manz, Antonia Maria Susanne Müller, Sascha David
Indications and Outcomes of Patients Receiving Therapeutic Plasma Exchange under Critical Care Conditions: A Retrospective Eleven-Year Single-Center Study at a Tertiary Care Center. Journal of clinical medicine 12 (8) (2023)
Veronika Lysenko, Patrick M Schürch, Selma Tuzlak, Nicole Wildner-Verhey van Wijk, Larisa V Kovtonyuk, Burkhard Becher, Markus Gabriel Manz, Stefanie Kreutmair, Alexandre P A Theocharides
Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model. Leukemia (2023)
Jacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, Thomas Pabst, Saskia K Klein, Georg Stussi, Laimonas Griskevicius, Peter J M Valk, Jacqueline Cloos, Arjan A van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus Gabriel Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W M van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J Ossenkoppele, null null, null null, Gerwin Huls
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine. Blood cancer journal 13 (1) (2023)
Jesse Marc Tettero, Yara Buisman, Lok Lam Ngai, Costa Bachas, Bjorn Tore Gjertsen, Angèle Kelder, Arjan A van de Loosdrecht, Markus Gabriel Manz, Thomas Pabst, Willemijn Scholten, Gert J Ossenkoppele, Jacqueline Cloos, David C de Leeuw
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML. HemaSphere 7 (12) (2023)
Veronika Lysenko, Patrick M Schürch, Selma Tuzlak, Nicole Wildner-Verhey van Wijk, Larisa V Kovtonyuk, Burkhard Becher, Markus Gabriel Manz, Stefanie Kreutmair, Alexandre P A Theocharides
Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model. Leukemia (2023)
Klara Kropivsek, Paul Kachel, Sandra Goetze, Rebekka Wegmann, Yasmin Festl, Yannik Severin, Benjamin D Hale, Julien Mena, Audrey van Drogen, Nadja Dietliker, Joëlle Tchinda, Bernd Wollscheid, Markus Gabriel Manz, Berend Snijder
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nature cancer (2023)
Alexander Ring, Wolfgang Alexander Sieber, Jan-Dirk Studt, Reto A Schuepbach, Christoph Camille Ganter, Markus Gabriel Manz, Antonia Maria Susanne Müller, Sascha David
Indications and Outcomes of Patients Receiving Therapeutic Plasma Exchange under Critical Care Conditions: A Retrospective Eleven-Year Single-Center Study at a Tertiary Care Center. Journal of clinical medicine 12 (8) (2023)
Veronika Lysenko, Patrick M Schürch, Selma Tuzlak, Nicole Wildner-Verhey van Wijk, Larisa V Kovtonyuk, Burkhard Becher, Markus Gabriel Manz, Stefanie Kreutmair, Alexandre P A Theocharides
Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model. Leukemia (2023)
Nadia Djerbi, Kathrin Zimmermann, Stefan Balabanov, Markus Gabriel Manz, Mike Oliver Becker, Marco Roncador
Intra-patient competition of VEXAS syndrome and CML clones. Blood advances (2023)
Abdullah Elsayed, Christian Pellegrino, Louis Plüss, Frederik Peissert, Ramon Benz, Franziska Ulrich, Gudrun Thorhallsdottir, Sheila Dakhel Plaza, Alessandra Villa, Jacqueline Mock, Emanuele Puca, Roberto De Luca, Markus Gabriel Manz, Cornelia Halin, Dario Neri
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties. mAbs 15 (1) (2023)
C Matthias Wilk, Larisa V Kovtonyuk, Markus Gabriel Manz
Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels. Blood advances 6 (15) (2022)
Francisco Caiado, Markus Gabriel Manz
TLR1/2-stimulated DCs "prime" HSCs via IL-1β. Blood 140 (14) (2022)
Francisco Caiado, Larisa V Kovtonyuk, Nagihan G Gonullu, Jonas Fullin, Steffen Boettcher, Markus Gabriel Manz
Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling. Blood (2022)
Jeroen J W M Janssen, B Löwenberg, Markus Gabriel Manz, B J Biemond, Peter E Westerweel, Saskia K Klein, M Fehr, H A M Sinnige, A Efthymiou, M C J C Legdeur, Thomas Pabst, M Gregor, M W M van der Poel, D Deeren, Lidwine W Tick, M Jongen-Lavrencic, F van Obbergh, R S Boersma, O de Weerdt, Yves Chalandon, D Heim, Olivier Spertini, G van Sluis, C Graux, G Stüssi, Y van Norden, G J Ossenkoppele
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome. Leukemia 36 (9) (2022)
Tim Grob, Mathijs Arnoud Sanders, Christian M Vonk, Franҫois G Kavelaars, Melissa Rijken, Diana W Hanekamp, Patrycja L Gradowska, Jacqueline Cloos, Yngvar Fløisand, Marinus van Marwijk Kooy, Markus Gabriel Manz, Gert J Ossenkoppele, Lidwine W Tick, Violaine Havelange, Bob Löwenberg, Mojca Jongen-Lavrencic, Peter J M Valk
Prognostic Value of FLT3 -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Stephan Isringhausen, YeVin Mun, Larisa V Kovtonyuk, Nike J Kräutler, Ute Suessbier, Alvaro Gomariz, Gianluca Spaltro, Patrick Michael Helbling, Hui Chyn Wong, Takashi Nagasawa, Markus Gabriel Manz, Annette Oxenius, Cesar Nombela-Arrieta
Chronic viral infections persistently alter marrow stroma and impair hematopoietic stem cell fitness. The Journal of experimental medicine 218 (12) (2021)
Nadia El Khawanky, Amy Hughes, Wenbo Yu, Renier Myburgh, Tony Matschulla, Sanaz Taromi, Konrad Aumann, Jade Clarson, Janaki Manoja Vinnakota, Khalid Shoumariyeh, Christoph Cornelius Miething, Angel F Lopez, Michael P Brown, Justus Duyster, Lutz Hein, Markus Gabriel Manz, Timothy P Hughes, Deborah L White, Agnes S M Yong, Robert Zeiser
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia. Nature communications 12 (1) (2021)
Francisco Caiado, Eric M Pietras, Markus Gabriel Manz
Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. The Journal of experimental medicine 218 (7) (2021)
Nicholas Favalli, Gabriele Bassi, Christian Pellegrino, Jacopo Millul, Roberto De Luca, Samuele Cazzamalli, Su Yang, Anika Trenner, Nour L Mozaffari, Renier Myburgh, Mustafa Moroglu, Stuart J Conway, Alessandro A Sartori, Markus Gabriel Manz, Richard A Lerner, Peter K Vogt, Jörg Scheuermann, Dario Neri
Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications. Nature chemistry 13 (6) (2021)
Irene A Abela, Chloé Pasin, Magdalena Schwarzmüller, Selina Epp, Michèle E Sickmann, Merle M Schanz, Peter Rusert, Jacqueline Weber, Stefan Schmutz, Annette Audigé, Liridona Maliqi, Annika Hunziker, Maria C Hesselman, Cyrille R Niklaus, Jochen Gottschalk, Eméry Schindler, Alexander Wepf, Urs Karrer, Aline Wolfensberger, Silvana K Rampini, Patrick Michael Meyer Sauteur, Christoph Berger, Michael Huber, Katharina Kusejko, Dominique L Braun, Maddalena Marconato, Markus Gabriel Manz, Beat M Frey, Huldrych F Gunthard, Roger D Kouyos, Alexandra Trkola
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity. Nature communications 12 (1) (2021)
Jeroen Janssen, Bob Löwenberg, Markus Gabriel Manz, Mario Bargetzi, Bart Biemond, Peter von dem Borne, Dimitri Breems, Rolf Brouwer, Yves Chalandon, Dries Deeren, Anna Efthymiou, Bjorn Tore Gjertsen, Carlos Graux, Michael Gregor, Dominik Heim, Urs Hess, Mels Hoogendoorn, Aurelie Jaspers, Kon-Siong G Jie, Mojca Jongen-Lavrencic, Saskia Klein, Marjolein van der Klift, Jürgen Kuball, Danielle van Lammeren-Venema, Marie-Cecile Legdeur, Arjan van de Loosdrecht, Johan A Maertens, Marinus van Marwijk Kooy, Ine Moors, Marten Nijziel, Florence van Obbergh, Margriet Oosterveld, Thomas Pabst, Marjolein van der Poel, Harm Sinnige, Olivier Spertini, Wim Terpstra, Lidwine Tick, Walter van der Velden, Marie-Christiane Vekemans, Edo Vellenga, Okke de Weerdt, Peter Westerweel, Georg Stüssi, Yvette van Norden, Gert Ossenkoppele
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers 13 (4) (2021)
Camille Bigenwald, Jessica Le Berichel, C Matthias Wilk, Rikhia Chakraborty, Steven T Chen, Alexandra Tabachnikova, Rebecca Mancusi, Harshal Abhyankar, Maria Casanova-Acebes, Ilaria Laface, Guray Akturk, Jenielle Jobson, Zoi Karoulia, Jerome Christophe Martin, John Grout, Anahita Rafiei, Howard Lin, Markus Gabriel Manz, Alessia Baccarini, Poulikos I Poulikakos, Brian D Brown, Sacha Gnjatic, Amaia Lujambio, Kenneth L McClain, Jennifer Picarsic, Carl E Allen, Miriam Merad
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology. Nature medicine 27 (5) (2021)
G J Ossenkoppele, D A Breems, G Stuessi, Y van Norden, M Bargetzi, B J Biemond, P A von dem Borne, Yves Chalandon, J Cloos, D Deeren, M Fehr, B Gjertsen, C Graux, G Huls, J J J W Janssen, A Jaspers, M Jongen-Lavrencic, E de Jongh, S K Klein, M van der Klift, M van Marwijk Kooy, J Maertens, L Michaux, M W M van der Poel, A van Rhenen, L Tick, P Valk, M C Vekemans, W J F M van der Velden, O de Weerdt, T Pabst, Markus Gabriel Manz, B Löwenberg, null null
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia 34 (7) (2020)
Renier Myburgh, Jonathan D Kiefer, Norman F Russkamp, Chiara F Magnani, Nicolás Gonzalo Nuñez, Alexander Simonis, Surema Pfister, C Matthias Wilk, Donal McHugh, Juliane Friemel, Antonia M Müller, Burkhard Becher, Christian Münz, Maries van den Broek, Dario Neri, Markus Gabriel Manz
Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells. Leukemia 34 (10) (2020)
Carsten Riether, Thomas Pabst, Sabine Höpner, Ulrike Bacher, Magdalena Hinterbrandner, Yara Banz, Rouven Müller, Markus Gabriel Manz, Walid H Gharib, David Francisco, Remy Bruggmann, Luc van Rompaey, Mahan Moshir, Tim Delahaye, Domenica Gandini, Ellen Erzeel, Anna Hultberg, Samson Fung, Hans de Haard, Nicolas Leupin, Adrian Franz Ochsenbein
Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nature medicine 26 (9) (2020)
Donal McHugh, Renier Myburgh, Nicole Caduff, Michael Spohn, Yik Lim Kok, Christian W Keller, Anita Murer, Bithi Chatterjee, Julia Rühl, Christine Engelmann, Obinna Chijioke, Isaak Quast, Mohaned Shilaih, Victoria P Strouvelle, Kathrin Neumann, Thomas Menter, Stephan Dirnhofer, Janice Kp Lam, Kwai Fung Hui, Simon Bredl, Erika Schlaepfer, Silvia Sorce, Andrea Zbinden, Riccarda Capaul, Jan D Lünemann, Adriano Aguzzi, Alan Kwok Shing Chiang, Werner Kempf, Alexandra Trkola, Karin J Metzner, Markus Gabriel Manz, Adam Grundhoff, Roberto F Speck, Christian Münz
EBV renders B cells susceptible to HIV-1 in humanized mice. Life science alliance 3 (8) (2020)
Francisco Caiado, Diogo Maia-Silva, Carolina Jardim, Nina Schmolka, Tânia Carvalho, Cláudia Reforço, Rita Faria, Branka Kolundzija, André E Simões, Tuncay Baubec, Christopher R Vakoc, Maria Gomes da Silva, Markus Gabriel Manz, Ton N M Schumacher, Håkan Norell, Bruno Silva-Santos
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection. Nature communications 10 (1) (2019)
Francisco Caiado, Diogo Maia-Silva, Carolina Jardim, Nina Schmolka, Tânia Carvalho, Cláudia Reforço, Rita Faria, Branka Kolundzija, André E Simões, Tuncay Baubec, Christopher R Vakoc, Maria Gomes da Silva, Markus Gabriel Manz, Ton N M Schumacher, Håkan Norell, Bruno Silva-Santos
Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection. Nature communications 10 (1) (2019)
Yuan-Bin Song, Anthony Rongvaux, Ashley Taylor, Tingting Jiang, Toma Tebaldi, Kunthavai Balasubramanian, Arun Bagale, Yunus Kasim Terzi, Rana Gbyli, Xiaman Wang, Xiaoying Fu, Yimeng Gao, Jun Zhao, Nikolai A Podoltsev, Mina Xu, Natalia Neparidze, Ellice Wong, Richard Torres, Emanuela M Bruscia, Yuval Kluger, Markus Gabriel Manz, Richard A Flavell, Stephanie Halene
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies. Nature communications 10 (1) (2019)
Markus Gabriel Manz, Norman F Russkamp
Selective CD117+ HSC exchange therapy. Blood 133 (19) (2019)
Markus Gabriel Manz
Plasmacytoid dendritic cells: origin matters. Nature immunology 19 (7) (2019)
Sonia Tugues, Ana Amorim, Sabine Spath, Guillaume Martin-Blondel, Bettina Schreiner, Donatella De Feo, Mirjam Lutz, Franco Guscetti, Petya Apostolova, Claudia Haftmann, Peter Hasselblatt, Nicolas G Núñez, Michael O Hottiger, Maries van den Broek, Markus Gabriel Manz, Robert Zeiser, Burkhard Becher
Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells. Science translational medicine 10 (469) (2019)
Alvaro Gomariz, Patrick Michael Helbling, Stephan Isringhausen, Ute Suessbier, Anton Sebastian Becker, Andreas Boss, Takashi Nagasawa, Grégory Paul, Orcun Goksel, Gábor Székely, Szymon Stoma, Simon F Nørrelykke, Markus Gabriel Manz, Cesar Nombela-Arrieta
Quantitative spatial analysis of haematopoiesis-regulating stromal cells in the bone marrow microenvironment by 3D microscopy. Nature communications 9 (1) (2018)
Wendelien Zeijlemaker, Tim Grob, Rosa Meijer, Diana Hanekamp, Angèle Kelder, Jannemieke C Carbaat-Ham, Yvonne J M Oussoren-Brockhoff, Alexander N Snel, Dennis Veldhuizen, Willemijn J Scholten, Johan Maertens, Dimitri A Breems, Thomas Pabst, Markus Gabriel Manz, Vincent H J van der Velden, Jennichjen Slomp, Frank Preijers, Jacqueline Cloos, Arjan A van de Loosdrecht, Bob Löwenberg, Peter J M Valk, Mojca Jongen-Lavrencic, Gert J Ossenkoppele, Gerrit J Schuurhuis
CD34+CD38- leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia 33 (5) (2018)